Below is Validea's guru fundamental report for MICROSTRATEGY INC (MSTR). Of the 22 guru strategies we follow, MSTR rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model looks for stocks with strong and co
Below is Validea's guru fundamental report for MICRON TECHNOLOGY INC (MU). Of the 22 guru strategies we follow, MU rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model looks for stocks with strong and co
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model looks for stocks with strong and consi
(RTTNews) - City Office REIT, Inc. (CIO) reported first-quarter FFO attributable to common stockholders of $12.47 million or $0.30 per share. Core FFO was approximately $13.5 million, or $0.33 per share. AFFO was approximately $9.1 million, or $0.22 per share, for the quarter.
It's hard to get out of paying taxes in general. But many people assume that once they start retirement, they'll be able to magically avoid owing the IRS money.
Procter & Gamble (NYSE: PG) performed very strongly through the inflation spike that occurred following coronavirus pandemic disruptions to supply chains, heated inflation, and rising interest rates. But the stock is trading within 5% of its all-time highs. That said, the com
(RTTNews) - French financial services provider Societe Generale S.A. reported Friday that its first-quarter net profit declined from last year amid nearly stable net revenues. Gross operating income, however, increased from the prior year. In Paris, Societe Generale shares were g
At its core, GoPro (NASDAQ: GPRO) makes cameras, which are not particularly exciting products, given that just about every cell phone is also a camera. What sets it apart is that GoPro cameras are built to withstand extreme and harsh treatment. The technology is, in fact, pretty
Commercial-stage biotech TG Therapeutics (NASDAQ: TGTX) was having a fine week on the stock exchange, thanks in no small part to an investor-pleasing earnings report. It unveiled its first-quarter fundamentals on Wednesday, and was quite the hot item in subsequent days. According